Table of Contents Author Guidelines Submit a Manuscript
Journal of Ophthalmology
Volume 2015, Article ID 369312, 9 pages
http://dx.doi.org/10.1155/2015/369312
Research Article

Responses of Multipotent Retinal Stem Cells to IL-1β, IL-18, or IL-17

1Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, MD 20892, USA
2Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou 510060, China
3Histology Core, National Eye Institute, National Institutes of Health, Bethesda, MD 20892, USA
4Stowers Institute for Medical Research, Kansas City, MO 64110, USA
5Department of Anatomy and Cell Biology, University of Kansas School of Medicine, Kansas City, KS 66160, USA

Received 29 March 2015; Accepted 14 July 2015

Academic Editor: Naoshi Kondo

Copyright © 2015 Shida Chen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. L. Dunaief, T. Dentchev, G.-S. Ying, and A. H. Milam, “The role of apoptosis in age-related macular degeneration,” Archives of Ophthalmology, vol. 120, no. 11, pp. 1435–1442, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Ambati, B. K. Ambati, S. H. Yoo, S. Ianchulev, and A. P. Adamis, “Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies,” Survey of Ophthalmology, vol. 48, no. 3, pp. 257–293, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Ambati, J. P. Atkinson, and B. D. Gelfand, “Immunology of age-related macular degeneration,” Nature Reviews Immunology, vol. 13, no. 6, pp. 438–451, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. V. Tarallo, Y. Hirano, B. D. Gelfand et al., “DICER1 loss and Alu RNA induce age-related macular degeneration via the NLRP3 inflammasome and MyD88,” Cell, vol. 149, no. 4, pp. 847–859, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. S. L. Doyle, M. Campbell, E. Ozaki et al., “NLRP3 has a protective role in age-related macular degeneration through the induction of IL-18 by drusen components,” Nature Medicine, vol. 18, no. 5, pp. 791–798, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. O. A. Anderson, A. Finkelstein, and D. T. Shima, “A2E induces IL-1β production in retinal pigment epithelial cells via the NLRP3 inflammasome,” PLoS ONE, vol. 8, no. 6, Article ID e67263, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. S. J. Lalor, L. S. Dungan, C. E. Sutton, S. A. Basdeo, J. M. Fletcher, and K. H. G. Mills, “Caspase-1-processed cytokines IL-1beta and IL-18 promote IL-17 production by gammadelta and CD4 T cells that mediate autoimmunity,” The Journal of Immunology, vol. 186, no. 10, pp. 5738–5748, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. L. S. Dungan and K. H. G. Mills, “Caspase-1-processed IL-1 family cytokines play a vital role in driving innate IL-17,” Cytokine, vol. 56, no. 1, pp. 126–132, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. J.-M. Doisne, V. Soulard, C. Bécourt et al., “Cutting edge: crucial role of IL-1 and IL-23 in the innate IL-17 response of peripheral lymph node NK1.1-invariant NKT cells to bacteria,” The Journal of Immunology, vol. 186, no. 2, pp. 662–666, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. L. Campillo-Gimenez, M.-C. Cumont, M. Fay et al., “AIDS progression is associated with the emergence of IL-17-producing cells early after simian immunodeficiency virus infection,” The Journal of Immunology, vol. 184, no. 2, pp. 984–992, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. B. Liu, L. Wei, C. Meyerle et al., “Complement component C5a promotes expression of IL-22 and IL-17 from human T cells and its implication in age-related macular degeneration,” Journal of Translational Medicine, vol. 9, article 111, 12 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. D. Ardeljan, Y. Wang, S. Park et al., “Interleukin-17 retinotoxicity is prevented by gene transfer of a soluble interleukin-17 receptor acting as a cytokine blocker: implications for age-related macular degeneration,” PLoS ONE, vol. 9, no. 4, Article ID e95900, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. L. Wei, B. Liu, J. Tuo et al., “Hypomethylation of the IL17RC promoter associates with age-related macular degeneration,” Cell Reports, vol. 2, no. 5, pp. 1151–1158, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Li, M. Lewallen, S. Chen, W. Yu, N. Zhang, and T. Xie, “Multipotent stem cells isolated from the adult mouse retina are capable of producing functional photoreceptor cells,” Cell Research, vol. 23, no. 6, pp. 788–802, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. Wang, D. Shen, V. M. Wang et al., “Enhanced apoptosis in retinal pigment epithelium under inflammatory stimuli and oxidative stress,” Apoptosis, vol. 17, no. 11, pp. 1144–1155, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. A.-J. F. Carr, M. J. K. Smart, C. M. Ramsden, M. B. Powner, L. da Cruz, and P. J. Coffey, “Development of human embryonic stem cell therapies for age-related macular degeneration,” Trends in Neurosciences, vol. 36, no. 7, pp. 385–395, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. K. Bharti, M. Rao, S. C. Hull et al., “Developing cellular therapies for retinal degenerative diseases,” Investigative Ophthalmology & Visual Science, vol. 55, no. 2, pp. 1191–1202, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Kaczmarek, P. Vandenabeele, and D. V. Krysko, “Necroptosis: the release of damage-associated molecular patterns and its physiological relevance,” Immunity, vol. 38, no. 2, pp. 209–223, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Linkermann and D. R. Green, “Necroptosis,” The New England Journal of Medicine, vol. 370, no. 5, pp. 455–465, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Degterev, Z. Huang, M. Boyce et al., “Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury,” Nature Chemical Biology, vol. 1, no. 2, pp. 112–119, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. D. Ofengeim and J. Yuan, “Regulation of RIP1 kinase signalling at the crossroads of inflammation and cell death,” Nature Reviews Molecular Cell Biology, vol. 14, no. 11, pp. 727–736, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. S. W. G. Tait, G. Ichim, and D. R. Green, “Die another way—non-apoptotic mechanisms of cell death,” Journal of Cell Science, vol. 127, part 10, pp. 2135–2144, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. C. P. Ardeljan, D. Ardeljan, M. Abu-Asab, and C. C. Chan, “Inflammation and cell death in age-related macular degeneration: an immunopathological and ultrastructural model,” Journal of Clinical Medicine, vol. 3, no. 4, pp. 1542–1560, 2014. View at Publisher · View at Google Scholar
  24. D. Ling, B. Liu, S. Jawad et al., “The tellurium redox immunomodulating compound AS101 inhibits IL-1beta-activated inflammation in the human retinal pigment epithelium,” The British Journal of Ophthalmology, vol. 97, no. 7, pp. 934–938, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. W. A. Tseng, T. Thein, K. Kinnunen et al., “NLRP3 inflammasome activation in retinal pigment epithelial cells by lysosomal destabilization: implications for age-related macular degeneration,” Investigative Ophthalmology and Visual Science, vol. 54, no. 1, pp. 110–120, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. S. H. Chang and C. Dong, “Signaling of interleukin-17 family cytokines in immunity and inflammation,” Cellular Signalling, vol. 23, no. 7, pp. 1069–1075, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. Y. Hu, F. Shen, N. K. Crellin, and W. Ouyang, “The IL-17 pathway as a major therapeutic target in autoimmune diseases,” Annals of the New York Academy of Sciences, vol. 1217, no. 1, pp. 60–76, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. R. Gold and F. Lühder, “Interleukin-17—extended features of a key player in multiple sclerosis,” The American Journal of Pathology, vol. 172, no. 1, pp. 8–10, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. W. T. Hu, A. Chen-Plotkin, M. Grossman et al., “Novel CSF biomarkers for frontotemporal lobar degenerations,” Neurology, vol. 75, no. 23, pp. 2079–2086, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. C.-C. Chan and D. Ardeljan, “Molecular pathology of macrophages and interleukin-17 in age-related macular degeneration,” Advances in Experimental Medicine and Biology, vol. 801, pp. 193–198, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. D. V. Jovanovic, J. A. Di Battista, J. Martel-Pelletier et al., “IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages,” The Journal of Immunology, vol. 160, no. 7, pp. 3513–3521, 1998. View at Google Scholar · View at Scopus
  32. S. Zrioual, M.-L. Toh, A. Tournadre et al., “IL-17RA and IL-17RC receptors are essential for IL-17A-induced ELR+ CXC chemokine expression in synoviocytes and are overexpressed in rheumatoid blood 1,” The Journal of Immunology, vol. 180, no. 1, pp. 655–663, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. R. Klein, C. E. Myers, K. J. Cruickshanks et al., “Markers of inflammation, oxidative stress, and endothelial dysfunction and the 20-year cumulative incidence of early age-related macular degeneration: the beaver dam eye study,” JAMA Ophthalmology, vol. 132, no. 4, pp. 446–455, 2014. View at Publisher · View at Google Scholar · View at Scopus
  34. S. Cao, A. Ko, M. Partanen et al., “Relationship between systemic cytokines and complement factor H Y402H polymorphism in patients with dry age-related macular degeneration,” American Journal of Ophthalmology, vol. 156, no. 6, pp. 1176–1183, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. E. Bettelli, Y. Carrier, W. Gao et al., “Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells,” Nature, vol. 441, no. 7090, pp. 235–238, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. C. E. Sutton, S. J. Lalor, C. M. Sweeney, C. F. Brereton, E. C. Lavelle, and K. H. G. Mills, “Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity,” Immunity, vol. 31, no. 2, pp. 331–341, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. C. Sutton, C. Brereton, B. Keogh, K. H. G. Mills, and E. C. Lavelle, “A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis,” The Journal of Experimental Medicine, vol. 203, no. 7, pp. 1685–1691, 2006. View at Publisher · View at Google Scholar · View at Scopus